These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8476884)

  • 1. Role of humoral immunity in acute cardiac allograft dysfunction.
    Costanzo-Nordin MR; Heroux AL; Radvany R; Koch D; Robinson JA
    J Heart Lung Transplant; 1993; 12(2):S143-6. PubMed ID: 8476884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
    Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
    Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral rejection in heart transplantation. Report of 2 cases].
    Castro P; Arriagada G; Moreno M; Morán S; Becker P; Zalaquett R; Godoy I; Córdova S
    Rev Med Chil; 2000 Nov; 128(11):1245-9. PubMed ID: 11347512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
    Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
    Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
    Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC
    Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corticoid-resistant rejection and humoral rejection. The diagnostic criteria and therapeutic management].
    Crespo Leiro MG; Portela Torrón F; Vázquez González N; Vázquez Rodríguez JM; Yebra Pimentel MT; González Cuesta M
    Rev Esp Cardiol; 1995; 48 Suppl 7():77-85. PubMed ID: 8775821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy.
    Jordan SC; Czer L; Toyoda M; Galfayan K; Doan D; Fishbein M; Blanche C; Trento A
    J Heart Lung Transplant; 1993; 12(2):333-7. PubMed ID: 8476907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasma cyclic GMP assay as a screening test for detection of acute cardiac allograft rejection.
    Stobierska-Dzierzek B; Surdacki A; Frasik W; Dziatkowiak A; Pietrucha A; Herman ZS; Piwowarska W
    J Heart Lung Transplant; 1998 Oct; 17(10):969-71. PubMed ID: 9811403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V; Venetz JP; Pantaleo G; Pascual M
    Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
    Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.